TS1017389552	mealTime 664 675	fed-fasting
TS217389552	food 887 893	liquid
TS617389552	sideeffect 1019 1027	headache
TS917389552	sideeffect 1030 1039	dizziness
T1	dosage 635 650	3 to 200 mg  kg
T2	dosage 723 732	50 mg  kg
T3	dosage 791 806	10 to 50 mg  kg
T4	frequency 813 834	twice per day ( bid )
T5	duration 839 852	up to 14 days
T6	drug 338 369	284-Dalton 1 , 2 , 4-oxadiazole
T7	drug 327 333	PTC124
T8	drugEffect 381 435	ribosomal readthrough of premature stop codons in mRNA
R1	has_effect Arg1:T7 Arg2:T8	
R2	has_effect Arg1:T6 Arg2:T8	
T9	dosage 978 996	150 and 200 mg  kg
T10	drug 999 1005	PTC124
R3	has_sideeffect Arg1:T10 Arg2:TS617389552	
R4	has_sideeffect Arg1:T10 Arg2:TS917389552	
T11	dosage 1100 1109	50 mg  kg
T12	frequency 1116 1119	bid
T13	drug 1386 1392	PTC124
T14	drug 1704 1710	PTC124
T15	drug 1743 1749	PTC124
T16	drug 1790 1796	PTC124
T17	drug 1922 1928	PTC124
T18	treatedDisease 1993 2020	Duchenne muscular dystrophy
T19	treatedDisease 1946 1988	nonsense mutation-mediated cystic fibrosis
R5	treat Arg1:T17 Arg2:T19	
R6	treat Arg1:T17 Arg2:T18	
